Non-Small Cell Lung Cancer Coverage from Every Angle
Editor:
David S. Ettinger, MD, FACP, FCCP
Advertisement
Advertisement

Ongoing CE Activities

Adding Local Tx Boosts Survival in Advanced NSCLC
Advanced/Metastatic NSCLC Treatment: Advancements for Patients Without Targetable Activating Mutations
Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
ALK- or ROS1-Rearranged NSCLC: Effectively Integrating Precision Medicine into Patient-Centered Care
Ask The Experts: The Evolution of Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Lung Cancer
Striving for (Roundtable Video Proceedings) Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer
Consensus or Controversy? The Integration of Novel Therapies into the Interdisciplinary Management of Non-Small Cell Lung Cancer with CNS Metastases
Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum
Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non–Small Cell Lung Cancer
Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma
Distilling Modern Medical Approaches in Advanced NSCLC: Precision, Performance, & Parallels with Patients
Enhancing Your Lung Cancer Practice: Applying Shared Decision Making in the Real-World
Faculty Rounds in NSCLC: Clinical Strategies for First- and Second-line Therapies and Beyond
First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches
Insights from the Latest Clinical Trials in Lung Cancer
Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice
Lung Cancer Update, Issue 1, 2020
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer
NCCN Pharmacy Updates: Updates on the Use of Immunotherapy & Targeted Therapy in NSCLC
Novel and Emerging Therapeutic Strategies in the Management of Non–Small Cell Lung Cancer
Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice
Optimizing Immunotherapy in NSCLC: Updates from Trials on Agents Targeting PD-L1
Practice Essentials for Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma
Precision Management in Non-Small Cell Lung Cancer: Addressing ALK+ Tumors
Proceedings from the First Annual Oncology Nursing Retreat-Targeted Treatment of Lung Cancer
'Smart Nose' Identifies Anti-PD-1 Response in NSCLC
(Faculty Presentations) Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer
Targeting Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Advances in Treatment
Time to Tailor NSCLC RT to Spare the Immune System?
Treatment Challenges in ALK+ NSCLC: Applying the Latest Clinical Guidance and Evidence to Complex Cases
Visiting Professors: Lung Cancer Edition, Issue 1, 2019
Yogurt, Fiber Consumption Linked to Lower Lung Cancer Risk
Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.